Page values for "AG2037"
Jump to navigation
Jump to search
"_pageData" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| _pageID | Integer | 853,795 |
| _pageName | Page | AG2037 |
| _pageTitle | String | AG2037 |
| _pageNamespace | Integer | 0 |
"definitions" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| Term | Page | AG2037 |
| Short_definition | String | AG2037 - A substance being studied for the treatment of cancer. It belongs to the family of glycinamide ribonucleotide formyltransferase inhibitors |
| Type | Page | Cancer terms |
| Specialty | Page | Oncology |
| Language | Page | English |
| Source | Page | NCI |
| Comments | String |